NCT01624792View on ClinicalTrials.gov

Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 25, 2011

Primary Completion Date

June 29, 2016

Study Completion Date

June 29, 2016

Conditions
Chronic Obstructive Pulmonary DiseaseMuscle Wasting
Interventions
DIETARY_SUPPLEMENT

Olive oil

Dose: 7.0 g/day (= 7 capsules/day).

DIETARY_SUPPLEMENT

Fish oil

Dose: 7.0 g/day (= 7 capsules/day = 3.5g EPA+DHA/day).

DIETARY_SUPPLEMENT

Fish oil and placebo

Dose: 7.0 g/day (= 4 capsules/day fish oil = 2.0g EPA+DHA/day and 3 capsules/day olive oil).

Trial Locations (1)

77843

Texas A&M University, College Station

All Listed Sponsors
lead

Texas A&M University

OTHER

NCT01624792 - Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2 | Biotech Hunter | Biotech Hunter